Effect of frailty on initiation of statins following incident acute coronary syndromes in patients aged ≥75 years

Decreasing mortality and increasing longevity in Australia and many countries have led to the clinical challenge of treating and caring for increasing numbers of frail older people with cardiovascular disease. Statin treatment, where tolerated, is an essential part of secondary prevention after an admission for acute coronary syndromes (ACS) [1]. A recent meta-analysis found that statins significantly reduced major vascular events and cardiovascular mortality independent of age together with a low risk of adverse effects [2].

Source: Maturitas - July 17, 2021 Category: Primary Care Authors: Derrick Lopez, Lee Nedkoff, Tom Briffa, David B. Preen, Christopher Etherton-Beer, Leon Flicker, Frank M Sanfilippo Source Type: research